Form 8-K - Current report:
SEC Accession No. 0001558370-20-013943
Filing Date
2020-11-17
Accepted
2020-11-17 17:18:44
Documents
14
Period of Report
2020-11-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20201117x8k.htm   iXBRL 8-K 34438
2 EX-99.1 tmb-20201117xex99d1.htm EX-99.1 133491
3 GRAPHIC tmb-20201117xex99d1001.jpg GRAPHIC 3419
  Complete submission text file 0001558370-20-013943.txt   307922

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20201117.xsd EX-101.SCH 3036
5 EX-101.LAB tmb-20201117_lab.xml EX-101.LAB 16739
6 EX-101.PRE tmb-20201117_pre.xml EX-101.PRE 10614
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20201117x8k_htm.xml XML 5084
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 201322060
SIC: 2834 Pharmaceutical Preparations